Why Is Perritt Capital Increasing Its Stake in iCAD?

2 min read | January 10, 2025 04:40 AM EST | By Team Kalkine Media

Highlights:

  • Perritt Capital Management raised its stake in iCAD by a significant margin.
  • The firm increased its holdings by over 14%, adding nearly 20,000 shares in the second quarter.
  • Institutional investors collectively own more than a quarter of iCAD's stock.

iCAD, Inc. (NASDAQ:ICAD) operates in the technology sector, with a focus on healthcare and diagnostic imaging solutions. The company develops advanced technologies that assist in the detection of cancer, using artificial intelligence and other high-tech innovations. This sector is crucial in advancing medical capabilities, particularly in the realm of cancer diagnostics, where early detection plays a vital role in improving treatment outcomes.

Recent Activity from Perritt Capital Management

In the second quarter, Perritt Capital Management Inc. made an adjustment to its holdings in iCAD. The hedge fund raised its stake by a notable amount, increasing its shareholding by more than 14%. This acquisition involved the purchase of additional shares, bringing the firm's total holdings to approximately 159,900 shares. With this move, Perritt Capital Management now owns around 0.60% of iCAD’s stock. This update is based on the most recent filing with the Securities and Exchange Commission (SEC), indicating the firm's growing position within the company.

Institutional Ownership of iCAD

A considerable portion of iCAD’s stock is held by institutional investors. As of the latest filings, institutional ownership stands at over a quarter of the company's shares. This reflects the interest of large financial entities in the stock, which can often influence the direction of a company’s growth or strategic moves. Institutional ownership can offer stability to a company, as these investors are generally seen as long-term holders.

iCAD's Technology and Market Position

iCAD has positioned itself as a leader in the field of artificial intelligence for medical imaging. By leveraging its technology, the company aims to enhance the capabilities of radiologists and other medical professionals in detecting various types of cancer. Through innovations like AI-powered imaging tools, iCAD continues to push the boundaries of how technology can improve healthcare outcomes. The technology sector, particularly in healthcare, is marked by rapid developments, and iCAD's role is central to the future of diagnostic technology.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.


Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.